Former Member of Parliament for Adentan, Kojo Adu Asare, has detailed his six-year fight against kidney failure. He faces a demanding dialysis schedule. A single session costs GHS 650. He needs three sessions each week.
This means his weekly treatment costs GHS 1,950. This adds up to approximately GHS 7,800 every month. Mr. Adu Asare noted that prices have increased over the years. He experienced costs of GHS 450, then GHS 550, and now GHS 650 per session. These rising costs place a heavy financial strain on patients and their families.
His story sheds light on the broader issue of healthcare access and affordability in Ghana. Chronic illnesses like kidney failure require long-term, expensive treatment. Many citizens struggle to afford such medical care. The cost of medication and other medical expenses further adds to the burden. This situation affects public health outcomes and household finances across the nation.
Mr. Adu Asare spoke out on Asempa FM’s Ekosiisen. He urged people to avoid unproven herbal remedies. He warned that these can worsen kidney conditions. He emphasized the need for proper medical care instead. "Once it gets to Stage Four, you are at end-stage. You are stuck," he stated. He advised seeking professional medical attention.
Despite the challenges, Mr. Adu Asare remains active. He manages his health condition while participating in public life. He credits support from various public figures and institutions for helping him navigate his illness. His experience calls for a national conversation on sustainable healthcare support for all kidney patients.
His personal journey highlights the urgent need for policy solutions. This includes potential subsidies for dialysis. Such measures could alleviate the financial pressure on patients. They would also improve long-term health management. The government faces increasing pressure to address these critical healthcare needs.
Mr. Adu Asare's testimony serves as a stark reminder. It underscores the intersection of health and economic well-being. The financial implications of chronic disease management are significant. They affect both individual citizens and the national economy. Future policy decisions will need to consider these substantial costs.
His ongoing treatment, even after a transplant, demonstrates the long-term impact of kidney disease. The GHS 7,800 monthly cost for dialysis is a substantial portion of many incomes. This issue requires urgent attention from policymakers.
The former MP's resilience is notable. He continues to engage in public discourse. However, his personal financial burden remains a critical point of discussion. This situation reflects systemic challenges in Ghana's healthcare financing model.